Oncovalent Therapeutics
Developer of Immuno oncology drugs intended to develop novel therapeutics to inhibit the human oncogene. The company develops small molecule drugs that are orally available and straightforward to synthesize used for aggressive lymphoma and colorectal cancers, thereby providing clients with products to address unmet medical needs.
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Oncovalent Therapeutics use?+
We have not yet detected technologies for Oncovalent Therapeutics.
What industry is Oncovalent Therapeutics in?+
Oncovalent Therapeutics operates in the Oncology industry.
Where is Oncovalent Therapeutics based?+
Oncovalent Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026